Breaking News Instant updates and real-time market news.

BIOS

BioScrip

$2.54

-0.005 (-0.20%)

08:56
06/13/18
06/13
08:56
06/13/18
08:56

BioScrip shares on 'cusp of really working,' says Barrington

BioScrip shares "are at the cusp of really working," Barrington analyst Michael Petusky tells investors in a research note. He keeps an Outperform rating on the stock with a $3.50 price target. The analyst believes much of the company's operational progress over the past couple of years "has been masked to some extent." The remainder of 2018's financial results are likely to come with less "noise" and better reflect the true operational improvements that have been executed at BioScrip over the past two years, the analyst contends.

BIOS BioScrip
$2.54

-0.005 (-0.20%)

03/09/18
BRRR
03/09/18
NO CHANGE
Target $3.5
BRRR
Outperform
BioScrip shares should be bought now, says Barrington
Barrington analyst Michael Petusky says BioScrip shares should be bought now following the 15.5% selloff on the company's Q4 results. BioScrip reported "strong" Q4 results, and the investment decisions weighing on the 2018 outlook make sense, Petusky tells investors in a research note. He maintains an Outperform rating on the shares with a $3.50 price target.
03/08/18
CHLM
03/08/18
NO CHANGE
Target $3.5
CHLM
Buy
BioScrip price target raised to $3.50 from $2.50 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich raised his price target for BioScrip to $3.50 and maintains a Buy rating on the shares. The stock is down due to an internal accounting review that could delay the annual report filing, but the company's Q4 results were better than expected, highlighted by significant gross margin expansion and solid free cash flow, Ellich tells investors in a post-earnings research note. The analyst thinks the company's adjusted EBITDA guidance could prove to be conservative. He admits, though, that it may "take time for the dust to settle" regarding the internal accounting review.
01/29/18
LSCM
01/29/18
NO CHANGE
Target $4.5
LSCM
Buy
BioScrip named a best idea for 2018 at Lake Street
Lake Street analyst Brooks O'Neil names BioScrip a best idea for 2018 following the stock's 180% rise in 2017. The analyst expects management to "continue to strengthen operations and deliver solid results in 2018." The analyst thinks that despite stalling in the Senate, the Cures Fix legislation will emerge for 2019. He keeps a Buy rating on BioScrip with a $4.50 price target.
12/19/17
JEFF
12/19/17
NO CHANGE
JEFF
Jefferies sees attractive leveraged buyout candidates in Healthcare Services
The changing healthcare landscape, as well as the cyclicality of sector trends and the expected demographics-driven inflection in broader healthcare utilization in the coming years, have opened opportunities for increased private equity involvement in the Healthcare Services group, Jefferies analyst Brian Tanquilut tells investors in a research note. The analyst's quantitative screen and qualitative analysis points to Acadia (ACHC), BioScrip (BIOS) and Envision Healthcare (EVHC) as the "most feasible" leverage buyout candidates in his coverage universe. Tanquilut notes that while AmerisourceBergen (ABC) and McKesson (MCK) also screened as potential leveraged buyout candidates in his analysis, the equity checks required to take both private are likely too large, even for a consortium.

TODAY'S FREE FLY STORIES

CE

Celanese

$112.15

7.65 (7.32%)

06:45
04/24/19
04/24
06:45
04/24/19
06:45
Conference/Events
Celanese management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

AVY

Avery Dennison

$115.99

2.085 (1.83%)

06:45
04/24/19
04/24
06:45
04/24/19
06:45
Earnings
Avery Dennison reports Q1 adjusted EPS $1.48, consensus $1.45 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 18

    May

06:45
04/24/19
04/24
06:45
04/24/19
06:45
General news
Breaking General news story  »

Week of 4/19 MBA Mortgage…

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

06:44
04/24/19
04/24
06:44
04/24/19
06:44
Periodicals
Coinbase shutters Chicago office, lays off about 30 engineers, Forbes reports »

Coinbase is shuttering…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TFX

Teleflex

$280.05

5.46 (1.99%)

06:43
04/24/19
04/24
06:43
04/24/19
06:43
Downgrade
Teleflex rating change  »

Teleflex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 13

    Nov

CDXC

ChromaDex

$4.22

0.225 (5.63%)

06:41
04/24/19
04/24
06:41
04/24/19
06:41
Hot Stocks
ChromaDex signs Tru Niagen distribution partnership in Canada with WELL Health »

ChromaDex announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$35.88

0.95 (2.72%)

06:41
04/24/19
04/24
06:41
04/24/19
06:41
Earnings
Boston Scientific narrows FY19 adj. EPS view to $1.54-$1.58 from $1.53-$1.58 »

Consensus $1.56. Narrows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 18

    May

  • 20

    May

  • 29

    May

  • 26

    Jun

  • 13

    Nov

TSEM

TowerJazz

$17.73

0.28 (1.60%)

06:40
04/24/19
04/24
06:40
04/24/19
06:40
Downgrade
TowerJazz rating change  »

Credit Suisse downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 28

    May

ZBH

Zimmer Biomet

$122.76

1.64 (1.35%)

06:39
04/24/19
04/24
06:39
04/24/19
06:39
Upgrade
Zimmer Biomet rating change  »

Zimmer Biomet upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 10

    May

NOC

Northrop Grumman

$292.59

9.73 (3.44%)

06:39
04/24/19
04/24
06:39
04/24/19
06:39
Hot Stocks
Northrop Grumman CEO says 'captured substantial new awards' in Q1 »

"In first quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 15

    May

  • 29

    May

CPF

Central Pacific

$29.52

0.62 (2.15%)

06:39
04/24/19
04/24
06:39
04/24/19
06:39
Earnings
Central Pacific reports Q1 EPS 55c, consensus 50c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 26

    Apr

RCKT

Rocket Pharmaceuticals

$19.32

1.54 (8.66%)

06:39
04/24/19
04/24
06:39
04/24/19
06:39
Conference/Events
Rocket Pharmaceuticals management to meet with Evercore ISI »

Luncheon with Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

NOC

Northrop Grumman

$292.59

9.73 (3.44%)

06:38
04/24/19
04/24
06:38
04/24/19
06:38
Earnings
Northrop Grumman raises FY19 adj. EPS view to $18.90-$19.30 from $18.50-$19.00 »

FY19 consensus $18.96.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 15

    May

  • 29

    May

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

06:37
04/24/19
04/24
06:37
04/24/19
06:37
Periodicals
SoftBank founder lost $130M on personal bitcoin investment, WSJ reports »

SoftBank Group (SFTBF)…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARX

RA Pharmaceuticals

$21.95

0.68 (3.20%)

06:37
04/24/19
04/24
06:37
04/24/19
06:37
Hot Stocks
RA Pharmaceuticals presents pre-clinical data for zilucoplan XR »

Ra Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKR

Acadia Realty Trust

$28.19

0.505 (1.82%)

06:36
04/24/19
04/24
06:36
04/24/19
06:36
Conference/Events
Acadia Realty Trust management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

  • 09

    May

  • 28

    May

  • 29

    May

  • 04

    Jun

PHM

PulteGroup

$31.34

1.11 (3.67%)

06:36
04/24/19
04/24
06:36
04/24/19
06:36
Upgrade
PulteGroup rating change  »

PulteGroup upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

BSX

Boston Scientific

$35.88

0.95 (2.72%)

06:36
04/24/19
04/24
06:36
04/24/19
06:36
Earnings
Boston Scientific sees Q2 adj. EPS 37c-39c, consensus 39c »

Sees Q2 revenue up 5%-7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 18

    May

  • 20

    May

  • 29

    May

  • 26

    Jun

  • 13

    Nov

NOC

Northrop Grumman

$292.59

9.73 (3.44%)

06:36
04/24/19
04/24
06:36
04/24/19
06:36
Earnings
Northrop Grumman reports Q1 EPS $5.06, consensus $4.58 »

Reports Q1 revenue $8.2B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 15

    May

  • 29

    May

FND

Floor & Decor

$47.36

2.04 (4.50%)

06:36
04/24/19
04/24
06:36
04/24/19
06:36
Recommendations
Floor & Decor analyst commentary  »

Floor & Decor price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 16

    May

PB

Prosperity Bancshares

$72.11

0.975 (1.37%)

06:35
04/24/19
04/24
06:35
04/24/19
06:35
Earnings
Prosperity Bancshares reports Q1 EPS $1.18, consensus $1.16 »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

TRK

Speedway Motorsports

$13.98

0.27 (1.97%)

06:34
04/24/19
04/24
06:34
04/24/19
06:34
Hot Stocks
Sonic Financial proposes to acquire Speedway Motorsports for $18.00 per share »

Speedway Motorsports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

BSX

Boston Scientific

$35.88

0.95 (2.72%)

06:33
04/24/19
04/24
06:33
04/24/19
06:33
Earnings
Boston Scientific reports Q1 adj. EPS 35c, consensus 36c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 18

    May

  • 20

    May

  • 29

    May

  • 26

    Jun

  • 13

    Nov

TSEM

TowerJazz

$17.73

0.28 (1.60%)

06:32
04/24/19
04/24
06:32
04/24/19
06:32
Downgrade
TowerJazz rating change  »

TowerJazz downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 28

    May

MKTX

MarketAxess

$262.60

0.44 (0.17%)

06:32
04/24/19
04/24
06:32
04/24/19
06:32
Earnings
MarketAxess reports Q1 EPS $1.39, consensus $1.37 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 02

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.